Loading clinical trials...
Loading clinical trials...
Placebo Controlled Study to Assess the Effect of Roflumilast in Hyperinflated COPD Patients in Addition to LABA/LAMA Therapy Using Functional Respiratory Imaging.
Conditions
Interventions
HRCT scan
Placebo of Roflumilast
+1 more
Locations
1
Belgium
University Hospital of Antwerp
Edegem, Antwerp, Belgium
Start Date
September 1, 2015
Primary Completion Date
August 31, 2017
Completion Date
August 31, 2017
Last Updated
March 21, 2018
NCT06712563
NCT07518472
NCT06831994
NCT05730088
NCT02755974
NCT07363980
Lead Sponsor
FLUIDDA nv
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions